.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Biomarkers in Breast Cancer
Gasparini, Giampietro; Hayes, Daniel F.
€ 250.89
FREE Delivery in Ireland
Description for Biomarkers in Breast Cancer
Hardback. Reviews how to design and evaluate studies of tumor markers and examines their use in breast cancer patients. This book covers various molecular methods and the prognostic and predictive indicators. It discusses the study design and guidelines for validation studies of various biomarkers, gene expression profiling by tissue microarrays, and more. Series: Cancer Drug Discovery and Development. Num Pages: 342 pages, 22 black & white illustrations, biography. BIC Classification: MBGR; MJCL; PSB. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 20. Weight in Grams: 675.
Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and ... Read more
Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and ... Read more
Product Details
Format
Hardback
Publication date
2005
Publisher
Humana Press Inc. United States
Number of pages
342
Condition
New
Series
Cancer Drug Discovery and Development
Number of Pages
342
Place of Publication
Totowa, NJ, United States
ISBN
9781588292278
SKU
V9781588292278
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Biomarkers in Breast Cancer